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Abstract 
 
 The family of serine/threonine proteins known as Aurora kinases have been 
shown to play an important role in cellular proliferation as key regulators of cell cycle 
progression in mitotic cells.  During meiosis, Aurora A is required for proper microtubule 
organization, establishing and sustaining spindle integrity, and proper chromatid 
alignment.  This study investigated the effects of demecolcine, a microtubule 
destabilizing drug, on spindle localization of Aurora A in CF-1 mouse oocytes prior to, 
during, and following parthenogenic activation.  This series of experiments tested the 
hypothesis that demecolcine enduced enuculation may affect critical cytoplasmic 
determinants required for proper embryo development.  Marked differences were 
observed between controls and demecolcine treated oocytes with respect to the 
disregulated spatial distribution of Aurora A.  In particular, dissimilarites in activation 
were observed after a period of only 20 minutes.  Demecolcine treated oocytes contained 
spindles that were slow to rotate and displayed continued expression of spindle pole 
localized Aurora A.  These results suggest that demecolcine disrupts cytoplasmic factors, 
such as Aurora A, in a time dependent manner.     
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Chapter 1: Introduction 
 
 Methods for conventional somatic cell nuclear transfer involve the process of 
inserting the genome of a donor into an enucleated oocyte.  This insertion is performed 
either via electroporation or microinjection; two procedures which are not only time 
consuming but also quite invasive and may contribute to the reported limited success of 
somatic cloning thus far (IbÆæez et. al., 2003).  These approaches may also deplete the 
oocyte cytoplasm of important factors that are required to complete subsequent 
development.  An alternative to mechanical enucleation which has been reported is a 
method of chemical enucleation that incorporates a microtubule destabilizing drug, 
demecolcine.  When activated oocytes are treated with demecolcine, they continue to 
undergo normal cytoplasmic division (cytokinesis) and thereby complete formation of the 
second polar body.  In contrast, nuclear division (karyokinesis) is disrupted causing all of 
the nuclear DNA to be extruded into the second polar body during the completion of 
meiosis II.  This procedure has been demonstrated to potentially increase the 
developmental competence of cloned embryos (IbÆæez et. al., 2003).    
 A significant problem associated with the conventional methods is, that following 
oocyte reconstruction, the nuclear transfer embryo demonstrates blocked cell cycle 
progression.  The family of Aurora kinases are known to be key cell cycle regulators, and 
Aurora A in particular is responsible for the regulation of microtubule-based spindle 
assembly (Yao et. al., 2004).  Increased microtubule organization is achieved through the 
phosphorylation of the centrosome protein TACC by the protein kinase, Aurora A (Brittle 
and Ohkura, 2005).  Studies on microtubule organizing centers have reported that the 
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presence of Aurora A is required for proper assembly (Tsai and Zheng, 2005) while over 
expression of Aurora A has been linked to breast, colorectal, and gastric cancers 
(Andrews, 2005).  Improper chromatid separation can result in the formation of tumors 
due to decreased gene stability and anuploidy (Bolanos-Garcia, 2005).  By observing the 
localization patterns of Aurora A in activated oocytes in response to demecolcine-
induced altered spindle integrity, conclusions can be made with respect to the role of this 
key cell cycle regulator in subsequent development of cloned embryos. 
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Chapter 2: Background 
 
Mouth pipetting 
 The standard method for moving oocytes is through a technique known as mouth 
pipetting.  Using an apparatus including a drawn-out glass Pasteur pipet, rubber tubing, a 
filter, and a mouth piece microscopic items can be transferred from one location to 
another.  Due to the small size of the oocytes (85 um) glass Pasteur pipets must be pulled 
to decrease their diameter.  Pulling pipets is a process by which a Pasteur pipet tip is 
introduced to a flame and, once heated, is pulled to a smaller diameter more suitable for 
the experimental model. 
 
Oocyte Manipulation 
 Before attempting to move actual oocytes, it is essential to become acquainted 
with the tools and methods that will be required.  In order to study the effects of 
demecolcine using a mouse model, oocytes must be collected from the donor, treated 
with the appropriate experimental conditions, and then stained to aid in the visualization 
the localization of structures and proteins.  This process requires the ability to accurately 
separate and transfer oocytes from one medium to another.  Familiarity with the 
stereomicroscope while using pulled Pasteur pipets for mouth pipetting can be aided 
through the use of blue beads.  While these beads are denser than actual oocytes they are 
a good representation of the small size.  Once comfortable with transferring blue beads, 
continued practice with fixed oocytes can aid not only in the ability to relocate them, but 
also to identify the difference between fragmented, lysed, and healthy oocytes. 
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Mouse Handling and Peritoneal Injections 
 Both hormones used to induce superovulation in female mice require the ability to 
properly administer peritoneal injections.  To be able to accurately inject the necessary 
hormones, proper handling that is both safe for the mouse and handler needs to be 
accomplished.  Mice can be restrained by holding the scruff close to the back of the head 
with the thumb and index finger while holding the tail down with the pinky finger.  A 
1/2 27 gauge needle on a 1ml syringe should be used to inject the proper hormone 
interperitoneally taking care to avoid the bladder.     
 
Collection procedure 
 The mouse donor must be humanely killed prior to harvesting the superovulated 
oocytes.  For this project mice were euthanized using carbon dioxide.  The animals were 
prepped with 70% ethanol prior to collection to reduce the possibility of contamination 
by mouse hair.  The skin over the abdomen is cut with surgical scissors and then pulled 
back to reveal the peritoneum.  Using forceps and smaller surgical scissors the 
peritoneum is then cut to expose the viscera.  Intestines should be moved to expose the 
uterus which needs to be separated from the mesometrium.  The uterus should be traced 
back to the ovary which can be held with watchmakers forceps.  Using the small surgical 
scissors the oviduct should be removed and placed in oocyte culture medium (FHM).  
Using the watchmakers forceps, a syringe, and a microscope the ampulla of the oviduct 
should be located and pierced to release the cumulus mass containing the oocytes.        
  
 
 9 
Chapter 3: Materials and Methods 
 
Collection of oocytes 
 Female CF-1 mice (Charles River Laboratories, MA) were superovulated using 
Pregnant Mare Serum Gonadatropin (PMS, 5IU) followed 48 hours later by human 
Chorionic Gonadatropin (hCG, 5IU).  Oocytes arrested at metaphase of meosis II (MII) 
were collected 16 hours post hCG in FHM.  Oocytes were denuded of adherent cumulus 
cells by brief incubation in the presence of hyaluronidase at 37°C, then washed, and 
fragmented oocytes were discarded.  Oocytes were randomly pooled and assigned to 
treatment groups. 
 
Experimental Design 
 Oocytes were activated by continuous exposure to strontium chloride (SrCl2, 
10mM) for 20 minutes, 45 minutes, 1.5 hours, 2 hours, and 4 hours.  Three groups were 
employed: a control group (MII-stage oocytes, n=37), a treatment control (activated 
oocytes, n=171), and a treatment group (oocytes activated in the presence of 0.4ug/ml 
demecolcine, n=162).  Additionally, an experiment was conducted to assess the 
reversibility of demecolcine treatment.  This consisted of oocytes (n=30) activated with 
SrCl2 and 0.4ug/ml demecolcine for 45 minutes and were then moved to demecolcine 
free activation medium for an additional 45 minutes.   
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Fixation, Staining, and Immunofluorescence Microscopy 
 All oocytes were fixed in 1% paraformaldehyde (PFA) with 0.15% Triton X-100 
in PBS for 30 minutes at 37°C either immediately after collection (MII) or at specific 
time points post-activation.  Oocytes were stained using antibodies specific to the desired 
cellular proteins.  Aurora A was stained using a primary rabbit anti-Aurora A polyclonal 
antibody (Zymed) followed by a secondary goat anti-rabbit IgG fragment labeled with 
alexa fluor 594 (5ug/ml, red, Molecular Probes).  Microtubules were probed with a 
primary mixture of mouse anti--tubulin and anti--tubulin monoclonal antibodies 
(1:1000 dilution, Sigma) followed by a secondary goat anti-mouse antibody labeled with 
alexa fluor 488 (5ug/ml, green, Molecular Probes).  Chromatin was stained using Hoechst 
33258 (10ug/ml, blue).  Stained oocytes were transferred to slides with mounting solution 
(50% glycerol, 50% PBS, 25mg/ml sodium azide), carefully covered with a cover slip, 
and sealed with clear nailpolish.  Imaging was performed using a Zeiss Axiovert 200M 
inverted microscope with a Roper CoolSnapFx CCD camera. MetaMorph software was 
used to collect images in real time.  
 
Antibody optimization 
 Prior to beginning the experimentation, a decision regarding antibody selection 
needed to be made.  When staining for Aurora A there are two options: either a 
monoclonal or a polyclonal antibody.  The benefit of the monoclonal antibody is its 
specificity, however if the desired target is rare in quantity, sufficient primary binding 
may limit visualization.  Alternatively, the second type of antibody, the polyclonal, will 
react with multiple epitopes specific to the protein of interest, thereby increasing 
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visualization.  In general, non-specific binding is reduced when using a monoclonal 
versus a polyclonal antibody and this feature needs to be taken into account.  In order to 
determine which type of antibody to use two optimization experiments were performed. 
 MII oocytes (total=128) were used to compare and determine the optimal 
concentration of a monoclonal and polyclonal Aurora A antibody with a minimum of 11 
oocytes in each treatment group.  Oocytes were introduced to varying concentrations of 
each antibody (1:100, 1:500, or 1:1000) or one of two negative control groups (primary 
antibody only, secondary antibody only) where block was used in place of the eliminated 
antibody.  After imaging the oocytes, it was concluded that the monoclonal antibody 
worked best at a concentration of 1:500, while the polyclonal antibody was clearest at a 
concentration of 1:100.  Based on the knowledge of the localization of Aurora A to the 
spindle poles, it was determined that the polyclonal antibody would be most appropriate 
for this experiment due to its compatability for co-localizatioin of tubulin staining using a 
monoclonal antibody.  The staining protocols used for the monoclonal and polyclonal 
antibodies can be found in Appendix A and B respectively.  
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Chapter 4: Results 
 
 As shown in previous reports, Aurora A was localized to the spindle poles in MII-
stage oocytes (Figure 1).  Following activation, the localization of Aurora A was 
diminished during anaphase of meiosis II (Figure 2 A&B, 3 A&B) and then relocalized at 
the spindle poles as the oocytes progressed to telophase of meiosis II (Figure 4 A&B).  
Upon reaching interphase (I), the Aurora A localization was once again reduced (Figure 5 
A&B).  The demecolcine treatment groups (Figures 2 C&D, 3 C&D, 4 C&D, 5 C&D) 
displayed not only disrupted microtubule organization and decreased spindle integrity but 
also altered Aurora A localization.  In these treatment groups, the activation process 
appeared to be delayed as indicated by lack of spindle rotation and the continued 
localization of Aurora A after 20 minutes.  In the later time points, lack of second polar 
body extrusion was observed in the demecolcine treated oocytes.  In the 1.5 hour 
recovery experiment (Figure 6), spindle integrity and rotation, and Aurora A localization 
did not revert to a normal phenotype within the observed time frame. 
 
A  B  
Figure 1: MII-stage oocyte stained for Aurora A (red), tubulin (green), and chromatin (blue) in the left 
image (A) and Aurora A and chromatin in the right image (B). 
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A  B 
C  D 
Figure 2: 20 minute activated control (A&B) and demecolcine treated (C&D) oocytes.  For each oocyte,  
Aurora A (red), tubulin (green), and chromatin (blue) staining is shown in the left image (A, C) and Aurora 
A and chromatin staining is shown in the right image (B,D). 
 
A  B 
C  D 
Figure 3: 45 minute activation control (A&B) and demecolcine treated (C&D) oocytes. For each oocyte,  
Aurora A (red), tubulin (green), and chromatin (blue) staining is shown in the left image (A,C) and Aurora 
A and chromatin staining is shown in the right image (B,D). 
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A  B 
C  D 
Figure 4: 2 hour activation control (A&B) and demecolcine treated (C&D) oocytes. For each oocyte,  
Aurora A (red), tubulin (green), and chromatin (blue) staining is shown in the left image (A,C) and Aurora 
A and chromatin staining is shown in the right image (B,D). 
 
A  B 
C  D 
Figure 5: 4 hour activation control (A&B) and demecolcine treated (C&D) oocytes. For each oocyte,  
Aurora A (red), tubulin (green), and chromatin (blue) staining is shown in the left image (A,C) and Aurora 
A and chromatin staining is shown in the right image (B,D) 
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A  B 
C  D 
E  F 
Figure 6: 1.5 hour activation control (A&B), demecolcine treated (C&D), and recovery (E&F) oocytes. 
For each oocyte,  Aurora A (red), tubulin (green), and chromatin (blue) staining is shown in the left image 
(A,C,E) and Aurora A and chromatin staining is shown in the right image (B,D,F) 
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Chapter 5: Discussion 
 
 Normal meiosis II progression is indicated by chromosomes lining up at the 
metaphase plate, followed by 90° spindle rotation, chromatid separation and segregation 
to the spindle poles, and the extrusion of the second polar body (IbÆæez et. al., 2003).  
The introduction of demecolcine into the activation medium results in altered spindle 
integrity due to the drugs microtubule depolymerizing properties.  A lack of spindle 
rotation in demecolcine treated oocytes has previously been reported (IbÆæez et. al., 
2003).  In this study, a similar effect was observed using strontium chloride as the 
activator.  Another similarity observed in these two studies is the lack of complete second 
polar body extrusion in the majority of demecolcine treated oocytes.  Here, like in the 
IbÆæez report (2003), the presence of demecolcine induces depolymerization of 
microtubules causing spindle collapse.  Similarities were also observed when compared 
to a study on Aurora A localization during fertilization and early embryo development 
(Yao et. al., 2004).  In both cases, Aurora A was localized to the spindle poles in MII-
stage mouse oocytes and then diffuse after the extrusion of the second polar body 
following 2-4 hours of activation. 
 In general, the demecolcine treated oocytes displayed delayed activation as 
indicated by deferred spindle rotation and residual Aurora A localization which differed 
from the patterns observed in control oocytes.  Additionally, there was a lack of observed 
second polar body extrusion in the treatment groups.  In the demecolcine recovery 
experiment, normal spindle configuration and Aurora A localization was not achieved in 
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the observed time frame.  This indicates a need for more information regarding the 
reversibility of demecolcine effects.    
 Based on these data, further studies should evaluate the effect of demecolcine on 
the timing and spatial expression of other key cell cycle regulators in activated 
mammalian oocytes.  Such information may lead to a better understanding of the cellular 
mechanisms that support successful somatic cell cloning. 
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Appendix A: Monoclonal Aurora A Staining Protocol 
Triple staining of mouse oocytes/embryos (Aurora A monoclonal, f-actin, chromatin) 
 
Fixed oocytes/embryos kept at 4 degrees C in block solution at least overnight before 
starting staining procedure. 
         Time  Temp  
1. Primary Ab: mouse anti Aurora A    60 min  37°C 
2. Wash in 0.5ml PBS/PVP     5 min  RT 
3. Block: block solution      30 min  RT 
4. Secondary Ab: goat anti-mouse IgG2b (Alexa 488)  45 min  37°C 
5. Wash in 0.5ml PBS/PVP     5 min  RT, 
dark 
6. Texas Red Phalloidin      30 min  37°C, 
dark 
7. Wash in 0.5ml PBS/PVP     5 min  RT, 
dark 
8. Hoechst 33258      10 min  RT, 
dark 
 
Primary Ab:  Aurora A (Mab) 1 ul stock + 499 ul block solution         (1:500) 
  
 
Secondary Ab: 5ul stock (10ug) + 495 ul block solution          (20ug/ml 
stock) 
(gam IgG2b)  250 ul of 20ug/ml stock + 750 ul block solution         (5ug/ml) 
 
Texas Red Phalloidin: 10 ul stock + 240 ul block solution           (8 U/ml) 
 
Hoechst 33258:  10 ul stock + 990 ul block solution           (10ug/ml) 
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Appendix B: Polyclonal Aurora A Staining Protocol 
Triple Staining of mouse oocytes/embryos (Aurora A polyclonal, tubulin, chromatin) 
 
Fixed oocytes/embryos kept at 4 degrees C in block solution at least overnight before 
starting staining procedure. 
         Time  Temp 
1. Primary Ab: rabbit anti Aurora A    60 min  37°C 
2. Wash in 0.5ml PBS/PVP     5 min  RT 
3. Block: block solution      30 min  RT 
4. Secondary Ab: gar IgG frag. (Alexa 594)   45 min  37°C, 
dark 
5. Wash in 0.5ml PBS/PVP     5 min  RT, 
dark 
6. Primary Ab: mouse anti a/b-tubulin cocktail (50:50)  60 min  37°C, 
dark 
7. Wash in 0.5ml PBS/PVP     5 min  RT, 
dark 
8. Block: block solution      30 min  RT, 
dark 
9. Secondary Ab: gam IgG1 (Alexa 488)   45 min  37°C, 
dark 
10. Wash in 0.5ml PBS/PVP     5 min  RT, 
dark 
11. Hoechst 33258      10 min  RT, 
dark 
 
Primary Ab:   a-tubulin: 2ul stock + 998 ul block solution          (1:500) 
              b-tubulin: 1.5ul stock + 120 ul block solution         (1:500) 
   a/b-tubulin cocktail: 200ul a-tubulin + 200ul b-tubulin     (1:1000) 
 
Primary Ab:   Aurora A (Pab) 5 ul stock + 495 ul block solution         (1:100) 
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Secondary Ab: 5ul stock (10ug) + 495 ul block solution          (20ug/ml 
stock) 
(gar IgG frag.)  250 ul of 20ug/ml stock + 750 ul block solution         (5ug/ml) 
 
Secondary Ab:  5ul stock (10ug) + 495 ul block solution          (20ug/ml 
stock) 
(gam IgG1)  250 ul of 20ug/ml stock + 750 ul block solution         (5ug/ml) 
 
Hoechst 33258:  10 ul stock + 990 ul block solution           (10ug/ml) 
 
 
